KRYS - Krystal Biotech GAAP EPS of -$1.17 beats by $0.05 November, 07 2022 08:18 AM Krystal Biotech Inc. Krystal Biotech press release ( NASDAQ: KRYS ): Q3 GAAP EPS of -$1.17 beats by $0.05 . Cash, cash equivalents, and investments totaled $407.0 million on September 30, 2022. For further details see: Krystal Biotech GAAP EPS of -$1.17 beats by $0.05